Anke Bio’s PEGylated human interferon α2b approved by the CFDA

The product can be used for the treatment of viral hepatitis, cancer and acute infectious diseases and will compete with Tonghua Dongbao’s PEGasys and Roche’s and Scheering-Plough’s products

China Bio news release, May 13, 2014

Most popular posts: